235 related articles for article (PubMed ID: 21527033)
21. Clinical and Microbiological Characteristics of Heteroresistant and Vancomycin-Intermediate Staphylococcus aureus from Bloodstream Infections in a Brazilian Teaching Hospital.
da Costa TM; Morgado PG; Cavalcante FS; Damasco AP; Nouér SA; Dos Santos KR
PLoS One; 2016; 11(8):e0160506. PubMed ID: 27575698
[TBL] [Abstract][Full Text] [Related]
22. Vancomycin susceptibility trends and prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in clinical methicillin-resistant S. aureus isolates.
Pitz AM; Yu F; Hermsen ED; Rupp ME; Fey PD; Olsen KM
J Clin Microbiol; 2011 Jan; 49(1):269-74. PubMed ID: 20962147
[TBL] [Abstract][Full Text] [Related]
23. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.
Capone A; Cafiso V; Campanile F; Parisi G; Mariani B; Petrosillo N; Stefani S
Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):625-31. PubMed ID: 26815434
[TBL] [Abstract][Full Text] [Related]
24. Dissemination of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus USA300 clone in multiple hospitals in Tokyo, Japan.
Takadama S; Nakaminami H; Sato A; Shoshi M; Fujii T; Noguchi N
Clin Microbiol Infect; 2018 Nov; 24(11):1211.e1-1211.e7. PubMed ID: 29454850
[TBL] [Abstract][Full Text] [Related]
25. Clonal change of methicillin-resistant Staphylococcus aureus isolated from patients with impetigo in Kagawa, Japan.
Sasai N; Nakaminami H; Iwasaki M; Iwao M; Misegawa K; Hasui M; Sato M; Yamamoto S; Yoshida T; Asano T; Senoue M; Ikeda M; Noguchi N
J Dermatol; 2019 Apr; 46(4):301-307. PubMed ID: 30803017
[TBL] [Abstract][Full Text] [Related]
26. Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis.
Nigo M; Diaz L; Carvajal LP; Tran TT; Rios R; Panesso D; Garavito JD; Miller WR; Wanger A; Weinstock G; Munita JM; Arias CA; Chambers HF
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28232309
[TBL] [Abstract][Full Text] [Related]
27. Dissemination of the Methicillin-resistant Staphylococcus aureus Pediatric Clone (ST5-T002-IV-PVL+) as a Major Cause of Community-associated Staphylococcal Infections in Bedouin Children, Southern Israel.
Rokney A; Baum M; Ben-Shimol S; Sagi O; Anuka E; Agmon V; Greenberg D; Valinsky L; Danino D
Pediatr Infect Dis J; 2019 Mar; 38(3):230-235. PubMed ID: 29912846
[TBL] [Abstract][Full Text] [Related]
28. [Community-acquired methicillin-resistant Staphylococcus aureus].
Cercenado E; Ruiz de Gopegui E
Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 13():19-24. PubMed ID: 19100163
[TBL] [Abstract][Full Text] [Related]
29. Nationwide surveillance study of vancomycin intermediate Staphylococcus aureus strains in Korean hospitals from 2001 to 2006.
Chung G; Cha J; Han S; Jang H; Lee K; Yoo J; Yoo J; Kim H; Eun S; Kim B; Park O; Lee Ys
J Microbiol Biotechnol; 2010 Mar; 20(3):637-42. PubMed ID: 20372039
[TBL] [Abstract][Full Text] [Related]
30. DNA microarray-based characterisation of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus from Italy.
Sanchini A; Campanile F; Monaco M; Cafiso V; Rasigade JP; Laurent F; Etienne J; Stefani S; Pantosti A
Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1399-408. PubMed ID: 21499956
[TBL] [Abstract][Full Text] [Related]
31. Vancomycin-heteroresistant phenotype in invasive methicillin-resistant Staphylococcus aureus isolates belonging to spa type 041.
Monaco M; Sanchini A; Grundmann H; Pantosti A;
Eur J Clin Microbiol Infect Dis; 2010 Jul; 29(7):771-7. PubMed ID: 20401508
[TBL] [Abstract][Full Text] [Related]
32. Methicillin-resistant Staphylococcus aureus ST30-SCCmec IVc clone as the major cause of community-acquired invasive infections in Argentina.
Fernandez S; de Vedia L; Lopez Furst MJ; Gardella N; Di Gregorio S; Ganaha MC; Prieto S; Carbone E; Lista N; Rotrying F; Stryjewski ME; Mollerach M
Infect Genet Evol; 2013 Mar; 14():401-5. PubMed ID: 23340226
[TBL] [Abstract][Full Text] [Related]
33. Production of extracellular polysaccharide and biofilm under different oxygen conditions by clinical isolates of Staphylococcus aureus non-susceptible to glycopeptides.
Szymanek-Majchrzak K; Wodzyńska S; Młynarczyk A; Młynarczyk G
Przegl Epidemiol; 2018; 72(4):487-498. PubMed ID: 30810004
[TBL] [Abstract][Full Text] [Related]
34. Clinical outcomes and treatment approach for community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections in Israel.
Berla-Kerzhner E; Biber A; Parizade M; Taran D; Rahav G; Regev-Yochay G; Glikman D
Eur J Clin Microbiol Infect Dis; 2017 Jan; 36(1):153-162. PubMed ID: 27677279
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic changes of methicillin-resistant Staphylococcus aureus during vancomycin therapy for persistent bacteraemia and related clinical outcome.
Kim T; Kim ES; Park SY; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Chong YP; Kim YS
Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1473-1481. PubMed ID: 28337607
[TBL] [Abstract][Full Text] [Related]
36. High frequency of SCCmec type V and agr type I among heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) in north India.
Singh A; Prasad KN; Rahman M; Rai RP; Singh SK; Srivastava JK
J Glob Antimicrob Resist; 2017 Mar; 8():110-114. PubMed ID: 28109847
[TBL] [Abstract][Full Text] [Related]
37. Relationship of agr expression and function with virulence and vancomycin treatment outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Seidl K; Chen L; Bayer AS; Hady WA; Kreiswirth BN; Xiong YQ
Antimicrob Agents Chemother; 2011 Dec; 55(12):5631-9. PubMed ID: 21968365
[TBL] [Abstract][Full Text] [Related]
38. An association between bacterial genotype combined with a high-vancomycin minimum inhibitory concentration and risk of endocarditis in methicillin-resistant Staphylococcus aureus bloodstream infection.
Miller CE; Batra R; Cooper BS; Patel AK; Klein J; Otter JA; Kypraios T; French GL; Tosas O; Edgeworth JD
Clin Infect Dis; 2012 Mar; 54(5):591-600. PubMed ID: 22186774
[TBL] [Abstract][Full Text] [Related]
39. [Investigation of SCCmec types and Panton-Valentine leukocidin in community-acquired and nosocomial Staphylococcus aureus strains: comparing skin and soft tissue infections to the other infections].
Gülmez D; Sancak B; Ercis S; Karakaya J; Hasçelik G
Mikrobiyol Bul; 2012 Jul; 46(3):341-51. PubMed ID: 22951646
[TBL] [Abstract][Full Text] [Related]
40. First reported case of infective endocarditis caused by community-acquired methicillin-resistant Staphylococcus aureus not associated with healthcare contact in Brazil.
Fortes CQ; Espanha CA; Bustorff FP; Zappa BC; Ferreira AL; Moreira RB; Pereira NG; Fowler VG; Deshmukh H
Braz J Infect Dis; 2008 Dec; 12(6):541-3. PubMed ID: 19287847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
